ZAI LAB (09688.HK) Latest Stock News - Major News Analysis

Quote List Quote List

Event Tracking

Nov11

UBS Maintains Buy Rating on Zai Lab Ltd With Price Target

00:36

Nov10

Zai Lab's Q3 Revenue Misses Expectations, Annual Guidance Cut

02:58

Nov6

Zai Lab Reports 14% Q3 Revenue Growth and Raises Full-Year Guidance

12:03

ZAI LAB released FY2025 9 Months Earnings on November 6 Pre-Market (BJT), actual revenue HKD 2.595 B, actual EPS HKD -0.8953

01:00

ZAI LAB released FY2025 Q3 earnings on November 6 Pre-Market (BJT), actual revenue HKD 903.53 M (forecast HKD 1.117 B), actual EPS HKD -0.2539 (forecast HKD -0.3613)

01:00

Nov4

Zai Lab Announces Termination of Bemarituzumab Gastric Cancer Clinical Trial

23:45

Schedules & Filings

Schedules

Filings

Nov6

Earning Release(CST)

FY2025 Q3 Earning Release (HKD) Revenue 903.53 M, Net Income -279.89 M, EPS -0.2539

Zai Lab Limited (ZLAB.US/09688.HK) Q3 2025 Earnings Conference Call

Aug7

Earning Release(CST)

FY2025 Q2 Earning Release (HKD) Revenue 863.31 M, Net Income -319.7 M, EPS -0.2927

May8

Earning Release(CST)

FY2025 Q1 Earning Release (HKD) Revenue 828.4 M, Net Income -376.82 M, EPS -0.3486

Zai Lab Limited (ZLAB.US/09688.HK) Q1 2025 Earnings Conference Call

Stock List

Top Gainers

Top Decliners

Main Board

Symbol

Price

%Chg

Change